FDA investigating how a known carcinogen wound up in J&J sunscreen

Reuters

Published Jul 16, 2021 05:41PM ET

By Michael Erman and Julie Steenhuysen

(Reuters) - The U.S. Food and Drug Administration (FDA) is investigating how a cancer-causing chemical ended up in Johnson & Johnson (NYSE:JNJ) sunscreens, after the company said it had done internal testing and found low levels of benzene in some, the regulator said on Friday.

J&J, which issued a voluntarily recall of the five different Neutrogena and Aveeno brand products, began testing after Valisure - an online pharmacy that tests its products for contaminants - found benzene in dozens of suncare products and asked the FDA to look into it in May.

"The root cause of the benzene found in recalled sunscreen products is the focus of ongoing investigation," FDA spokesman Jeremy Kahn said. "We will continue to monitor sunscreen manufacturing and marketing to help ensure the availability of safe sunscreens for U.S. consumers."

On Friday, Valisure Chief Executive David Light said in an interview that he believes the benzene will likely be traced to contaminated raw materials and that he does not believe that the problem is inherent to aerosol sunscreens, or sunscreens in general. "There's probably the most evidence for raw material contamination," Light said. He said that is because the contamination was found in a scattered fashion among brands, and even within brands, suggesting that it was unlikely to be a problem with the chemical or mineral active ingredients.

Valisure also found benzene in products made by other companies than J&J. CVS has halted sales of two of its sunburn healing products, which were in Valisure's petition.